143 related articles for article (PubMed ID: 36382719)
1. The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study.
Rasooli R; Ramezankhani A; Khalili D; Tohidi M; Hasheminia M; Azizi F; Hadaegh F
Ann Med; 2022 Dec; 54(1):3258-3268. PubMed ID: 36382719
[TBL] [Abstract][Full Text] [Related]
2. Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008-2011.
Moazzeni SS; Ghafelehbashi H; Hasheminia M; Parizadeh D; Ghanbarian A; Azizi F; Hadaegh F
BMC Public Health; 2020 Oct; 20(1):1510. PubMed ID: 33023566
[TBL] [Abstract][Full Text] [Related]
3. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
[TBL] [Abstract][Full Text] [Related]
4. Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.
Kabootari M; Asgari S; Ghavam SM; Abdi H; Azizi F; Hadaegh F
J Transl Med; 2021 Jun; 19(1):277. PubMed ID: 34193200
[TBL] [Abstract][Full Text] [Related]
5. New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population.
Hadaegh F; Fahimfar N; Khalili D; Sheikholeslami F; Azizi F
Cardiovasc Diabetol; 2010 Dec; 9():84. PubMed ID: 21129219
[TBL] [Abstract][Full Text] [Related]
6. Association between glucose tolerance and mortality among Japanese community-dwelling older adults aged over 75 years: 12-year observation of the Tosa Longitudinal Aging Study.
Tatsuno M; Wada T; Kato E; Hirayama K; Fujisawa M; Kimura Y; Ishimoto Y; Hirosaki M; Nose M; Yamada C; Kohori-Segawa H; Kasahara Y; Yamamoto N; Okumiya K; Matsubayashi K; Sakamoto R
Geriatr Gerontol Int; 2023 May; 23(5):341-347. PubMed ID: 36992614
[TBL] [Abstract][Full Text] [Related]
7. Silent coronary artery disease and incidence of cardiovascular and mortality events at different levels of glucose regulation; results of greater than a decade follow-up.
Hadaegh F; Ehteshami-Afshar S; Hajebrahimi MA; Hajsheikholeslami F; Azizi F
Int J Cardiol; 2015 Mar; 182():334-9. PubMed ID: 25585379
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study.
Parizadeh D; Rahimian N; Akbarpour S; Azizi F; Hadaegh F
Eur J Prev Cardiol; 2019 Jul; 26(10):1080-1091. PubMed ID: 30862232
[TBL] [Abstract][Full Text] [Related]
9. Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study.
Moazzeni SS; Hizomi Arani R; Deravi N; Hasheminia M; Khalili D; Azizi F; Hadaegh F
Cardiovasc Diabetol; 2021 Jul; 20(1):141. PubMed ID: 34253199
[TBL] [Abstract][Full Text] [Related]
10. Three-year change in glycemic state and the future risk of incident hypertension among Iranian adults: Tehran Lipid and Glucose Study.
Moazzeni SS; Dehghani S; Hasheminia M; Hizomi Arani R; Azizi F; Hadaegh F
J Hum Hypertens; 2023 Oct; 37(10):944-949. PubMed ID: 36473941
[TBL] [Abstract][Full Text] [Related]
11. Changes in Fasting plasma glucose status and risk of mortality events in individuals without diabetes over two decades of Follow-up: a pooled cohort analysis.
Kohansal K; Masrouri S; Khalili D; Ramezankhani A; Azizi F; Blaha MJ; Hadaegh F
Cardiovasc Diabetol; 2022 Dec; 21(1):267. PubMed ID: 36463152
[TBL] [Abstract][Full Text] [Related]
12. Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS).
Hadaegh F; Khalili D; Fahimfar N; Tohidi M; Eskandari F; Azizi F
J Endocrinol Invest; 2009 Oct; 32(9):724-30. PubMed ID: 19574728
[TBL] [Abstract][Full Text] [Related]
13. Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
Alizadeh Z; Baradaran HR; Kohansal K; Hadaegh F; Azizi F; Khalili D
Front Endocrinol (Lausanne); 2022; 13():1041808. PubMed ID: 36277718
[TBL] [Abstract][Full Text] [Related]
14. Incidence and predictors of early adulthood pre-diabetes/type 2 diabetes, among Iranian adolescents: the Tehran Lipid and Glucose Study.
Mirbolouk M; Derakhshan A; Charkhchi P; Guity K; Azizi F; Hadaegh F
Pediatr Diabetes; 2016 Dec; 17(8):608-616. PubMed ID: 26764014
[TBL] [Abstract][Full Text] [Related]
15. Different combinations of glucose tolerance and blood pressure status and incident cardiovascular disease and all-cause mortality events.
Hajebrahimi MA; Akbarpour S; Eslami A; Azizi F; Hadaegh F
J Hum Hypertens; 2017 Nov; 31(11):744-749. PubMed ID: 28748918
[TBL] [Abstract][Full Text] [Related]
16. Resting heart rate and the risk of incident type 2 diabetes mellitus among non-diabetic and prediabetic Iranian adults: Tehran lipid and glucose study.
Moazzeni SS; Karimi Toudeshki K; Ghorbanpouryami F; Hasheminia M; Azizi F; Pishgahi M; Hadaegh F
BMC Public Health; 2023 Oct; 23(1):2112. PubMed ID: 37891510
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, awareness, treatment, and control of type 2 diabetes mellitus among the adult residents of tehran: Tehran Cohort Study.
Oraii A; Shafiee A; Jalali A; Alaeddini F; Saadat S; Masoudkabir F; Vasheghani-Farahani A; Heidari A; Sadeghian S; Boroumand M; Karimi A; H Franco O
BMC Endocr Disord; 2022 Oct; 22(1):248. PubMed ID: 36253738
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes - a 10-year follow-up: Tehran Lipid and Glucose Study.
Afsharian S; Akbarpour S; Abdi H; Sheikholeslami F; Moeini AS; Khalili D; Momenan AA; Azizi F; Hadaegh F
Diabetes Metab Res Rev; 2016 Sep; 32(6):596-606. PubMed ID: 26787367
[TBL] [Abstract][Full Text] [Related]
19. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
[TBL] [Abstract][Full Text] [Related]
20. Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
Tapp RJ; Shaw JE; Zimmet PZ; Balkau B; Chadban SJ; Tonkin AM; Welborn TA; Atkins RC
Am J Kidney Dis; 2004 Nov; 44(5):792-8. PubMed ID: 15492944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
